Katharine Bowker1, Katarzyna A Campbell2, Tim Coleman2, Sarah Lewis3, Felix Naughton4, Sue Cooper2. 1. Division of Primary Care, University of Nottingham, Nottingham, United Kingdom; Katharine.bowker@nottingham.ac.uk. 2. Division of Primary Care, University of Nottingham, Nottingham, United Kingdom; 3. Division of Epidemiology and Public Health, Nottingham City Hospital, Nottingham, United Kingdom; 4. Behavioural Science Group, Institute of Public Health, University of Cambridge, Cambridge, United Kingdom.
Abstract
BACKGROUND: Pregnant smokers may be offered nicotine replacement therapy (NRT) alongside behavioral support to assist with a quit attempt. Yet trials of NRT have found adherence to be low among pregnant women, and this has made it difficult to determine the efficacy of NRT. The aim of this study is to understand the experience of pregnant women who use NRT but discontinue this early or do not use the medication as recommended. METHODS: Semi-structured telephone interviews were conducted with 14 pregnant smokers who had recently been prescribed NRT, but self-reported poor NRT adherence or discontinuing treatment prematurely. Data were transcribed and analyzed using inductive thematic analysis RESULTS: There were four main themes identified; expectations of NRT, experience of using NRT, safety concerns and experience of using e-cigarettes. Some women intentionally used NRT to substitute a proportion of their cigarette intake and smoked alongside. Most women smoked while using NRT. Women who underutilized NRT did so as they experienced side effects, or were concerned that using NRT instead of smoking could actually increase their nicotine exposure and potential for increased nicotine dependence or fetal harm. Most women spoke about the use of e-cigarettes as a smoking cessation method but only a few had actually experienced using them during pregnancy. CONCLUSION: Many women underused NRT but simultaneously smoked. Challenging negative perceptions about NRT and educating women further about the risks of smoking may encourage them to use NRT products as recommended. IMPLICATIONS: These findings add to the research surrounding the efficacy of NRT during pregnancy by providing insight into how pregnant women use NRT during a quit attempt and how this may influence adherence. It may assist health professionals to support pregnant smokers by increasing their understanding about the differing ways in which women use NRT and help them address concerns women may have about the safety of NRT.
BACKGROUND: Pregnant smokers may be offered nicotine replacement therapy (NRT) alongside behavioral support to assist with a quit attempt. Yet trials of NRT have found adherence to be low among pregnant women, and this has made it difficult to determine the efficacy of NRT. The aim of this study is to understand the experience of pregnant women who use NRT but discontinue this early or do not use the medication as recommended. METHODS: Semi-structured telephone interviews were conducted with 14 pregnant smokers who had recently been prescribed NRT, but self-reported poor NRT adherence or discontinuing treatment prematurely. Data were transcribed and analyzed using inductive thematic analysis RESULTS: There were four main themes identified; expectations of NRT, experience of using NRT, safety concerns and experience of using e-cigarettes. Some women intentionally used NRT to substitute a proportion of their cigarette intake and smoked alongside. Most women smoked while using NRT. Women who underutilized NRT did so as they experienced side effects, or were concerned that using NRT instead of smoking could actually increase their nicotine exposure and potential for increased nicotine dependence or fetal harm. Most women spoke about the use of e-cigarettes as a smoking cessation method but only a few had actually experienced using them during pregnancy. CONCLUSION: Many women underused NRT but simultaneously smoked. Challenging negative perceptions about NRT and educating women further about the risks of smoking may encourage them to use NRT products as recommended. IMPLICATIONS: These findings add to the research surrounding the efficacy of NRT during pregnancy by providing insight into how pregnant women use NRT during a quit attempt and how this may influence adherence. It may assist health professionals to support pregnant smokers by increasing their understanding about the differing ways in which women use NRT and help them address concerns women may have about the safety of NRT.
Authors: Laura J Fish; Bercedis L Peterson; Rebecca J Namenek Brouwer; Pauline Lyna; Cheryl A Oncken; Geeta K Swamy; Evan R Myers; Pamela K Pletsch; Kathryn I Pollak Journal: Nicotine Tob Res Date: 2009-04-07 Impact factor: 4.244
Authors: Selina Baeza-Loya; Humsini Viswanath; Asasia Carter; David L Molfese; Kenia M Velasquez; Philip R Baldwin; Daisy G Y Thompson-Lake; Carla Sharp; J Christopher Fowler; Richard De La Garza; Ramiro Salas Journal: Bull Menninger Clin Date: 2014
Authors: Allison M Glasser; Lauren Collins; Jennifer L Pearson; Haneen Abudayyeh; Raymond S Niaura; David B Abrams; Andrea C Villanti Journal: Am J Prev Med Date: 2016-11-30 Impact factor: 5.043
Authors: Robert Schnoll; E Paul Wileyto; Robert Gross; Brian Hitsman; Larry W Hawk; Paul Cinciripini; Tony P George; Neal L Benowitz; Su Fen Lubitz; Rebecca Ashare; Rachel F Tyndale; Caryn Lerman Journal: Drug Alcohol Depend Date: 2020-03-20 Impact factor: 4.492
Authors: Xi Wang; Kang Zhao; Sarah Cha; Michael S Amato; Amy M Cohn; Jennifer L Pearson; George D Papandonatos; Amanda L Graham Journal: Decis Support Syst Date: 2018-10-15 Impact factor: 5.795
Authors: Lisa McDaid; Ross Thomson; Joanne Emery; Tim Coleman; Sue Cooper; Lucy Phillips; Felix Naughton Journal: Int J Environ Res Public Health Date: 2021-04-28 Impact factor: 3.390
Authors: Bhavandeep Slaich; Ravinder Claire; Joanne Emery; Sarah Lewis; Sue Cooper; Ross Thomson; Lucy Phillips; Darren Kinahan-Goodwin; Felix Naughton; Lisa McDaid; Miranda Clark; Anne Dickinson; Tim Coleman Journal: Addiction Date: 2021-09-20 Impact factor: 7.256
Authors: Katarzyna Campbell; Thomas Coleman-Haynes; Katharine Bowker; Sue E Cooper; Sarah Connelly; Tim Coleman Journal: Cochrane Database Syst Rev Date: 2020-05-22
Authors: Katarzyna A Campbell; Libby Fergie; Tom Coleman-Haynes; Sue Cooper; Fabiana Lorencatto; Michael Ussher; Jane Dyas; Tim Coleman Journal: Int J Environ Res Public Health Date: 2018-02-17 Impact factor: 3.390
Authors: Katharine Bowker; Sophie Orton; Sue Cooper; Felix Naughton; Rachel Whitemore; Sarah Lewis; Linda Bauld; Lesley Sinclair; Tim Coleman; Anne Dickinson; Michael Ussher Journal: BMC Pregnancy Childbirth Date: 2018-06-15 Impact factor: 3.007